Does diabetes shorten your life?

The question expects a number. The records answer with a slope more than a number: the same disease leaves a different trace in follow-up by age at diagnosis. When records of people diagnosed at forty are set beside those diagnosed at sixty, the distance doesn’t come out small. So the answer’s weight falls on what it depends on.

The broadest study of this relationship pooled nearly a hundred mutually independent follow-up cohorts and one large population record in one analysis. In those records the death-rate gap against the comparison group widened steadily as diagnosis came earlier. Translated into life expectancy, each ten years of earlier diagnosis matched roughly three to four years of difference. The rows below compare two group averages. None of them is a single person’s arithmetic.

The table’s numbers were derived from population death rates, computed over records of people who reached fifty; they don’t show one person’s years ahead. The years the records come from also spread wide; decades separate the oldest follow-ups from the newest.

The lifespan question isn’t only about the body. The World Health Organization reports that over half of people living with diabetes used no medication at all for this diagnosis in the year of the count. That is a second measure beside the follow-up results: reaching treatment itself.

An observational follow-up measures the second half of the question from elsewhere. People living with type 2 diabetes were set beside a comparison group matched for age and sex. Five measures were followed: HbA1c, the cholesterol line among blood fats, albumin in the urine, smoking, and blood pressure. These are all measures with a counterpart at the exam and on the lab sheet. The article asking what gets followed besides sugar, “What else gets checked besides blood sugar?”, looks at each of these measures separately. In the group with all five measured inside the target range, extra death risk became almost invisible. That is a comparison result; the records don’t measure the same person in two states.

One detail leaves the picture as it stands. The heart attack side’s difference pointed downward; on the stroke side no meaningful separation remained. Hospital admission for heart failure, in contrast, stayed above the comparison group even with all five measures on target. Heart failure means the heart can’t push blood through the body hard enough; it shows as breathlessness and swelling collecting in the feet. So the extra risk doesn’t close all at once; the part that does is a measured result. What the same targets mean on the organ side is the next question. The article “Can complications be prevented?” completes this picture.

The distance between the two measurements is the answer itself. An average shrinks a population’s sum to one number and describes no one inside it. Age at diagnosis can’t be taken back. Where the five measures stand, though, keeps being measured through follow-up, and those records are still piling up.